IP Library Assignment 023379/0789
Patent Assignment
Reel/Frame 023379/0789

Third Amended and Restated Patent Security Agreement

Recorded: 2009-10-15 Pages: 8
Assignor
ALAVEN PHARMACEUTICAL LLC
Executed: 2009-09-16
Assignee
GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
500 W. MONROE, CHICAGO, ILLINOIS, 60661
Covered Properties (5)
Composition and Method for Treating Iron Deficiency Anemia
Improved Reduced Irritant Enema for the Treatment of Inflammatory Bowel Disease (Ibd)
Composition and Method for Treating Iron Deficiency Anemia
Patent: 7,585,527 →
Application: 11/230,042 →
Publication: US 2007/0065521
Reduced Irritant Enema for Treatment of Inflammatory Bowel Disease (Ibd)
Patent: 7,645,801 →
Application: 11/749,732 →
Publication: US 2008/0183142
Composition and Method for Treating Iron Deficiency Anemia
Patent: 8,080,520 →
Application: 12/506,139 →
Publication: US 2009/0281021
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement Apr 11, 2006
From: ALAVEN PHARMACEUTICAL, LLC
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 017470/0531 →
Assignment of Assignor's Interest Jun 28, 2007
From: GUTHRIE, MICHAEL
To: COLORADO BIOLABS INC.
Reel/Frame 019494/0035 →
Amended & Restated Patent Security Agreement Mar 25, 2008
From: ALAVEN PHARMACEUTICAL, LLC
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 020724/0843 →
Second Amended & Restated Patent Security Agreement Dec 16, 2008
From: ALAVEN PHARMACEUTICAL LLC
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 021993/0146 →
Assignment of Assignor's Interest Jul 10, 2009
From: VENKATARAMAN, BALA; BROWN, LINDSEY; PATEL, DAXA
To: ALAVEN PHARMACEUTICAL, LLC
Reel/Frame 022938/0735 →
Assignment of Assignor's Interest Feb 3, 2010
From: GUTHRIE, MICHAEL
To: COLORADO BIOLABS, INC.
Reel/Frame 023892/0173 →
Assignment of Assignor's Interest Feb 3, 2010
From: VENKATARAMAN, BALA
To: ALAVEN PHARMACEUTICAL, LLC
Reel/Frame 023892/0155 →
Release of Security Interest Oct 7, 2010
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: ALAVEN PHARMACEUTICAL LLC
Reel/Frame 025105/0550 →
Assignment of Assignor's Interest May 12, 2021
From: MEDA AB; ALAVEN PHARMACEUTICAL LLC
To: NURYA BRANDS, INC.
Reel/Frame 056210/0968 →